NewAmsterdam Pharma Company N.V. logo NAMS - NewAmsterdam Pharma Company N.V.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $51.33 DETAILS
HIGH: $58.00
LOW: $45.00
MEDIAN: $51.00
CONSENSUS: $51.33
UPSIDE: 141.55%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Revenue
Revenue 3.7 3.0 0.0 0.3 19.1 3.0 12.8 29.1 2.3 1.4 0.8 2.9 1.7 8.6 5.5 5.5 49.0 51.7 0 0 0 0 0 0 0 0
Cost of Revenue 0 0.5 0.1 0 0 0 0 0 0 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 3.7 2.5 (0.0) 0.3 19.1 3.0 12.8 29.1 2.3 1.4 0.8 2.9 1.7 8.6 5.5 5.5 49.0 51.7 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 41.7 37.5 38.6 31.0 27.5 44.8 34.9 35.7 38.4 42.4 41.3 43.4 34.3 40.4 28.4 28.4 16.0 16.9 9.9 9.5 0 5.0 0 1.0 1.0 1.0
SG&A Expenses 26.9 23.4 27.4 24.5 27.3 27.2 24.3 17.3 15.3 13.9 8.7 9.1 9.9 6.8 5.2 5.2 4.9 5.1 1.9 0.7 0.3 0.8 0.1 0.3 0.3 0.3
Other Expenses 0 0 0 0 0 0 (3.2) 1.1 1.2 0 1.9 0 0 1.2 0 0 0.0 0.0 6.3 7.1 0 0.0 0 (2.7) (2.7) (2.7)
Operating Expenses 68.6 61.0 66.0 55.5 54.8 71.9 56.0 54.1 54.9 56.3 51.9 52.5 44.2 48.5 33.6 33.6 20.9 22.1 18.0 17.3 0.3 5.8 0.1 (1.4) (1.4) (1.4)
Operating Income
Operating Income (64.9) (58.4) (66.0) (55.1) (35.6) (68.9) (43.2) (25.0) (52.6) (55.0) (51.1) (49.6) (42.5) (39.9) (28.1) (28.1) 28.1 29.7 (18.0) (17.3) (0.3) (5.8) (0.1) (3.8) (3.8) (3.8)
Interest Expense 0 0 0 0 0 0 0 0 0 0 1.7 1.0 3.1 1.2 0.0 0 0 0 0 0 0 0 0 0.1 0.1 0.1
Interest Income 5.8 4.0 6.5 6.7 7.1 7.4 4.5 4.4 4.9 3.1 2.5 2.7 4.2 0.9 0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0
Profitability
EBITDA (59.7) (48.4) (74.9) (71.9) (17.3) (39.5) (111.7) (23.8) (51.4) (54.9) (51.0) (46.2) (35.2) (38.6) (38.0) (38.0) 28.6 30.2 (12.4) (11.5) (0.3) (5.8) 0.0 (1.4) (1.4) (1.4)
EBIT (59.8) (48.4) (74.9) (72.0) (17.4) (39.5) (111.7) (23.9) (51.4) (55.0) (51) (46.2) (35.2) (38.6) (38.0) (38.0) 28.6 30.2 (12.4) (11.5) (0.3) (5.8) 0.0 (1.4) (1.4) (1.4)
Income Before Tax (64.1) (48.4) (74.9) (72.0) (17.4) (39.5) (92.2) (16.6) (39.0) (93.8) (49.5) (47.1) (38.3) (42.0) (38.0) (38.0) 28.6 30.2 (20.1) (11.1) (1.3) (5.6) 0.0 (4.2) (4.2) (4.2)
Income Tax Expense 0 0 0 0 0 0 0 (0.0) 0 0 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (64.1) (48.4) (74.9) (72.0) (17.4) (39.5) (92.2) (16.6) (39.0) (93.8) (49.5) (47.1) (38.3) (42.0) (38.0) (38.0) 28.6 30.2 (20.1) (11.1) (1.3) (5.6) 0.0 (1.4) (1.4) (1.4)
Per Share Data
EPS (Basic) -0.52 -0.40 -0.65 -0.61 -0.15 -0.34 -0.98 -0.18 -0.41 -1.06 -0.52 -0.56 -0.43 -0.47 -2.20 -23.19 0.75 0.75 -1.73 -0.82 -0.07 -0.43 0.00 -0.02 -0.02 -0.02
EPS (Diluted) -0.52 -0.40 -0.65 -0.61 -0.15 -0.34 -0.98 -0.18 -0.41 -1.06 -0.52 -0.56 -0.43 -0.47 -2.20 -23.22 0.67 0.68 -1.73 -0.82 -0.07 -0.43 0.00 -0.02 -0.02 -0.02
Shares Outstanding 123.4 121.1 114.4 119.0 112.5 116.1 97.0 94.8 94.7 88.4 82.5 82.5 81.8 81.6 18.4 17.8 17.8 17.8 17.8 17.8 17.8 17.8 17.8 86.1 86.1 86.1
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Current Assets
Cash & Cash Equivalents 424.2 457.6 490.0 538.4 563.9 748.4 771.7 422.7 430.7 481.1 340.4 418.7 418.7 467.7 467.7 467.7 93.7 99.0 60.4 61.5 0.8 1.2 1.4 2.0 2.0 2.0
Short-Term Investments 209.7 178.5 146.2 164.5 175.3 60.1 62.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Receivables 24.0 8.2 23.2 20.2 0 1.6 21.3 5.1 0 0 0 0 0 0 0 0 120.5 127.2 5.5 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 1.4 1.3 1.3 1.3 19.8 0 0 0 5.4 4.1 1.9 (418.7) 0 (467.7) 2.1 2.1 1.7 1.8 (0.6) 5.0 0 0 0 0.3 0.3 0.3
Total Current Assets 659.2 658.0 675.7 732.3 769.9 817.3 863.4 437.9 445.4 487.8 346.8 0 425.0 0 478.0 478.0 227.3 240.0 67.0 68.2 1.2 1.6 1.9 2.3 2.3 2.3
Non-Current Assets
Property, Plant & Equipment 0.5 0.4 0.6 0.6 0.6 0.6 0.7 0.7 0.8 0.1 0.1 0 0.1 0 0.2 0.2 0.2 0.2 0.2 0.2 0 0 0 0.0 0.0 0.0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0.3 0.4 0.4 0.4 0.5 0.5 0.5 0.6 0.5 0.5 0.2 0 0 0 0.2 0.2 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 44.4 0 0 53.1 44.2 0 0 0 0 0 0 0 0 0 0 0 0 0 138.0 0 138.0 138.0 138.0 0 0 0
Other Non-Current Assets 0 73.8 92.6 0 0 0 0 0 0.0 0.0 0.0 0 89.2 0 0.2 0.2 0.8 0.8 (137.2) 0.8 0 0 0 0 0 0
Total Non-Current Assets 45.2 74.6 93.6 54.1 45.3 1.1 1.2 1.3 1.3 0.6 0.3 0 89.3 0 0.5 0.5 0.9 1.0 1.0 1.1 138.0 138.0 138.0 0.0 0.0 0.0
Total Assets 704.5 732.6 769.3 786.4 815.1 818.4 864.6 439.2 446.7 488.5 347.1 0 514.3 0 478.5 478.5 228.2 241.0 68.0 69.2 139.2 139.6 139.9 2.3 2.3 2.3
Current Liabilities
Account Payables 5.4 8.1 9.0 3.6 5.9 6.1 4.7 7.0 5.3 8.5 16.9 0 22.8 0 11.9 11.9 12.3 13.0 7.1 7.2 0 0 0.2 0.1 0.1 0.1
Short-Term Debt 0 0.0 0.1 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0 0 2.9 2.9 2.9
Deferred Revenue 2.8 4.0 4.0 0 0 3.0 6.0 4.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 54.5 55.3 72.7 48.6 20.9 29.6 91.0 29.5 29.6 41.2 21.5 0 19.0 0 18.0 18.0 14.7 15.6 0 0 0.1 0.2 0.1 0.2 0.2 0.2
Total Current Liabilities 73.0 67.4 85.8 58.3 36.5 40.9 106.9 41.3 45.3 59.7 49.9 0 41.9 0 36.1 36.1 27.1 28.7 11.2 11.4 0.1 0.2 0.2 3.2 3.2 3.2
Non-Current Liabilities
Long-Term Debt 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 18.8 13.6 16.9 8.8 (461.0) 11.4 (430.1) 12.3 12.3 7.8 8.2 0 0 10.1 9.1 12.2 0 0 0
Total Non-Current Liabilities 0.1 0 0.1 0.1 0.1 0.1 0.2 19.1 13.9 16.9 8.8 (461.0) 11.5 (430.1) 12.4 12.4 7.9 8.3 0.1 0.1 10.1 9.1 12.2 0 0 0
Total Liabilities 73.0 67.4 85.9 58.4 36.6 41.0 107.1 60.3 59.3 76.7 58.7 (461.0) 53.3 (430.1) 48.4 48.4 35.0 37.0 11.4 11.6 10.2 9.4 12.4 3.2 3.2 3.2
Stockholders' Equity
Common Stock 14.7 14.6 14.3 14.1 14.0 14.0 13.4 11.4 11.2 11.1 10.2 0 10.8 0 10.1 10.1 0.2 0.2 0.1 0.1 124.0 125.3 122.5 0.6 0.6 0.6
Retained Earnings (875.0) (810.8) (762.4) (687.5) (615.5) (598.1) (558.6) (466.4) (449.7) (410.7) (317.0) 0 (212.3) 0 (140.0) (140.0) 20.8 21.9 (39.4) (40.2) 1.6 2.9 0.0 (1.5) (1.5) (1.5)
Accumulated Other Comprehensive Income 3.9 4.2 4.8 4.6 4.3 4.4 4.5 4.4 4.4 4.4 4.4 461.0 8.7 430.1 4.4 4.4 1.1 1.1 0.7 0.7 0 0 0 (0.0) (0.0) (0.0)
Total Stockholders' Equity 631.4 665.2 683.4 728.1 778.5 777.4 757.5 378.9 387.4 411.8 288.4 461.0 461.0 430.1 430.1 430.1 193.2 204.0 56.6 57.7 129.0 130.3 127.5 (0.9) (0.9) (0.9)
Total Liabilities & Equity 704.5 732.6 769.3 786.4 815.1 818.4 864.6 439.2 446.7 488.5 347.1 0 514.3 0 478.5 478.5 228.2 241.0 68.0 69.2 139.2 139.6 139.9 2.3 2.3 2.3
Debt Metrics
Total Debt 0.1 0.0 0.2 0.3 0.3 0.4 0.4 0.5 0.6 0.0 0.1 0 0.1 0 0.1 0.1 0.2 0.2 0.2 0.2 0.0 0 0 2.9 2.9 2.9
Net Debt (424.1) (457.6) (489.8) (538.1) (563.5) (748.0) (771.3) (422.2) (430.1) (481.1) (340.4) (418.7) (418.6) (467.7) (467.6) (467.6) (93.6) (98.8) (60.2) (61.3) (0.8) (1.2) (1.4) 0.9 0.9 0.9
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Operating Activities
Net Income (64.1) (48.4) (74.9) 39.5 (17.4) (39.5) (92.2) (16.6) (39.0) (93.8) (49.5) (46.1) (38.3) (42.0) (38.0) (4.8) (1.2) 1.4 0.9 1.7 (1.3) 2.8 (1.4) (1.4) (1.4) (1.4)
Depreciation & Amortization 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0 0.0 0.0 0.0 0.0
Stock-Based Compensation 18.4 0 0 15.0 15.2 15.2 9.4 0 8.3 7.9 6.0 5.6 5.6 7.6 1.9 0 0 0 0 0 0 0 0 0 0 0
Change in Working Capital 1.4 4.1 4.6 (10.4) (23.8) 10.4 (8.0) 0.0 (14.6) (10.1) 9.3 2.6 3.0 (0.6) 53.2 2.1 1.8 (0.0) 0.0 0.2 (0.1) 0.0 (0.1) (0.1) (0.1) (0.1)
Other Non-Cash Items 5.0 13.7 29.4 (77.0) (11.7) (22.6) 53.2 4.1 (8.7) 41.4 1.1 2.6 0.4 3.1 10.1 2.5 (0.8) (1.7) (0.4) (2.1) 1.0 (3.1) 0.1 0.1 0.1 0.1
Operating Cash Flow (39.2) (30.6) (40.9) (32.8) (37.7) (36.5) (37.5) (12.5) (54.0) (54.6) (33.1) (35.3) (29.3) (31.9) 29.2 (0.2) (0.2) (0.4) 0.6 (0.2) (0.4) (0.2) (1.5) (1.5) (1.5) (1.5)
Investing Activities
Capital Expenditure (0.1) (0.0) (0.1) (0.0) (0.1) (0.0) (0.0) (0.1) (0.2) (0.4) (0.0) (0.0) (0.0) (0.0) (0.1) 0.0 0 (0.0) (0.0) (0.0) 0 0 (0.0) (0.0) (0.0) (0.0)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (51.2) (62.5) (71.5) (31.9) (183.7) (9.6) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 46.5 51 50.5 34.4 24.7 12.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 (62.2) 0 0 0 0 (2.6) 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0.0 0.0
Investing Cash Flow (4.8) (11.5) (21.1) 2.5 (159.1) 2.9 (62.2) (0.1) (0.2) (0.4) (0.0) (2.6) (0.0) (0.0) (0.1) 0 0 0 0 0 0 0 (0.0) (0.0) (0.0) (0.0)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 0 0 6.5 1.6 0 0 7.7 0 0.2 6.3 2.4 156.9 0 0 0 0 0 0 0 2.8 2.8 2.8 2.8
Financing Cash Flow 11.0 11.1 13.7 5.9 3.4 6.5 456.6 0.1 4.7 198.2 0 0.2 6.3 2.4 156.9 0 0 (0.0) 0 0 0 0 2.8 2.8 2.8 2.8
Cash Position
Net Change in Cash (33.4) (32.4) (48.4) (24.1) (184.6) (23.3) 349.0 (8.0) (50.4) 140.7 (27.9) (32.7) (24.6) (26.4) 467.7 (0.2) (0.2) (0.4) 0.6 (0.2) (0.4) (0.2) 1.3 1.3 1.3 1.3
Cash at Beginning 458.9 491.3 539.7 563.9 748.4 771.7 422.7 430.7 481.1 340.4 368.3 381.9 441.3 467.7 0.4 0.6 0.8 1.2 0.6 0.8 1.2 1.4 0.6 0.6 0.6 0.6
Cash at End 425.5 458.9 491.3 539.7 563.9 748.4 771.7 422.7 430.7 481.1 340.4 349.2 416.7 441.3 467.7 0.4 0.6 0.8 1.2 0.6 0.8 1.2 2.0 2.0 2.0 2.0
Free Cash Flow (39.3) (30.6) (41.0) (32.8) (37.8) (36.5) (37.5) (12.6) (54.2) (55.0) (33.1) (35.3) (29.3) (31.9) 29.1 (0.2) (0.2) (0.4) 0.6 (0.2) (0.4) (0.2) (1.5) (1.5) (1.5) (1.5)
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Income Statement
Revenue 3.7 3.0 0.0 0.3 19.1 3.0 12.8 29.1 2.3 1.4 0.8 2.9 1.7 8.6 5.5 5.5 49.0 51.7 0 0 0 0 0 0 0 0
Gross Profit 3.7 2.5 (0.0) 0.3 19.1 3.0 12.8 29.1 2.3 1.4 0.8 2.9 1.7 8.6 5.5 5.5 49.0 51.7 0 0 0 0 0 0 0 0
Operating Income (64.9) (58.4) (66.0) (55.1) (35.6) (68.9) (43.2) (25.0) (52.6) (55.0) (51.1) (49.6) (42.5) (39.9) (28.1) (28.1) 28.1 29.7 (18.0) (17.3) (0.3) (5.8) (0.1) (3.8) (3.8) (3.8)
Net Income (64.1) (48.4) (74.9) (72.0) (17.4) (39.5) (92.2) (16.6) (39.0) (93.8) (49.5) (47.1) (38.3) (42.0) (38.0) (38.0) 28.6 30.2 (20.1) (11.1) (1.3) (5.6) 0.0 (1.4) (1.4) (1.4)
EPS (Diluted) -0.52 -0.40 -0.65 -0.61 -0.15 -0.34 -0.98 -0.18 -0.41 -1.06 -0.52 -0.56 -0.43 -0.47 -2.20 -23.22 0.67 0.68 -1.73 -0.82 -0.07 -0.43 0.00 -0.02 -0.02 -0.02
Balance Sheet
Cash & Equivalents 424.2 457.6 490.0 538.4 563.9 748.4 771.7 422.7 430.7 481.1 340.4 418.7 418.7 467.7 467.7 467.7 93.7 99.0 60.4 61.5 0.8 1.2 1.4 2.0 2.0 2.0
Total Assets 704.5 732.6 769.3 786.4 815.1 818.4 864.6 439.2 446.7 488.5 347.1 0 514.3 0 478.5 478.5 228.2 241.0 68.0 69.2 139.2 139.6 139.9 2.3 2.3 2.3
Total Debt 0.1 0.0 0.2 0.3 0.3 0.4 0.4 0.5 0.6 0.0 0.1 0 0.1 0 0.1 0.1 0.2 0.2 0.2 0.2 0.0 0 0 2.9 2.9 2.9
Stockholders' Equity 631.4 665.2 683.4 728.1 778.5 777.4 757.5 378.9 387.4 411.8 288.4 461.0 461.0 430.1 430.1 430.1 193.2 204.0 56.6 57.7 129.0 130.3 127.5 (0.9) (0.9) (0.9)
Cash Flow
Operating Cash Flow (39.2) (30.6) (40.9) (32.8) (37.7) (36.5) (37.5) (12.5) (54.0) (54.6) (33.1) (35.3) (29.3) (31.9) 29.2 (0.2) (0.2) (0.4) 0.6 (0.2) (0.4) (0.2) (1.5) (1.5) (1.5) (1.5)
Capital Expenditure (0.1) (0.0) (0.1) (0.0) (0.1) (0.0) (0.0) (0.1) (0.2) (0.4) (0.0) (0.0) (0.0) (0.0) (0.1) 0.0 0 (0.0) (0.0) (0.0) 0 0 (0.0) (0.0) (0.0) (0.0)
Free Cash Flow (39.3) (30.6) (41.0) (32.8) (37.8) (36.5) (37.5) (12.6) (54.2) (55.0) (33.1) (35.3) (29.3) (31.9) 29.1 (0.2) (0.2) (0.4) 0.6 (0.2) (0.4) (0.2) (1.5) (1.5) (1.5) (1.5)